A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma
Prediction of Lymph Node Metastasis in Hepatocellular Carcinoma and the Study of Individualized Radiotherapy
Objectives:
- To further validate the predictive efficacy of our established microRNA prediction model of HCC lymph node metastasis.
- To establish a precise therapeutic mode of prophylactic radiation therapy in high-risk patients with HCC with lymph node metastasis under the guidance of a microRNA prediction model.
研究概览
详细说明
First, screening out patients who underwent hepatic tumor resection and pathologically diagnosed as HCC .
Then,performing the detection of miR-145, miR-31 and miR-92a by using the HCC lymph node metastasis microRNA correlation prediction model established in our previous study. The patients are judged as high risk of lymph node metastasis and low risk Patients, then high-risk patients under the condition of informed consent into the group, randomized into treatment group and control groups.
Last, Patients enrolled in the treatment group were treated with radiotherapy and followed up.
研究类型
注册 (预期的)
阶段
- 不适用
联系人和位置
学习地点
-
-
-
Shanghai、中国、200032
- 招聘中
- 180 Fenglin Road
-
接触:
- Zhaochong Zeng, Phd
- 电话号码:86-13817076800
- 邮箱:zeng.zhaochong@zs-hospital.sh.cn
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- patients underwent liver tumor resection and pathological diagnosis of HCC in our hospital.
- The tumor samples of these HCC patients were detected by in situ hybridization with miR-145, miR-31 and miR-92a. We used the previously established HCC lymph node metastasis microRNA prediction model to determine the patients with high-risk lymph node metastasis and low-risk patients at high risk Patients were randomly assigned into treatment group and control group with informed consent.
- HCC patients were not receive other anti-cancer treatment.
- Blood routine examination was normal.
- Child-Pugh grade A, normal liver and kidney function in the normal range (including ALT or ASL within 2.5 times the normal), WBC> 3 × 109 / L, Hb> 90g / L, PLT> 50 × 109 /
- HCC patients were not receive the history of upper abdominal radiotherapy.
- sign the informed consent.
- age 18-75 years old.
- KPS score 80-100 points.
Exclusion Criteria:
- accepted other anti-cancer treatment.
- Patients was determined to be low-risk lymph node metastasis by the pre-established HCC lymph node metastasis microRNA prediction model.
- blood and liver and kidney dysfunction.
- can not control the infection.
- at the same time the merger of other malignant tumors.
- while using other experimental drugs or to participate in other clinical trials.
- serious heart, lung, kidney disease.
- pregnant or lactating women.
- serious nervous system disease, can not clearly tell the treatment
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Radiotherapy
Patients in the experimental group, who were at high risk for lymph node metastasis, underwent radiotherapy in the lymphatic drainage area.
Radiotherapy was started in lymphatic drainage areas about 1 month after HCC surgery.
The range of radiotherapy was hepatic portal area, pancreas circumference, celiac trunk and abdomen Around the aortic lymph drainage area, the dose of radiation 45Gy, conventional segmentation.
|
放疗
|
|
无干预:Blank control
Patients in the control group , who were at high risk for lymph node metastasis,were followed up.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
2-year overall survival
大体时间:The outcome measures are assessed up to 2 years.
|
The therapeutic effects are mainly evaluated by the 2-year overall survival.
|
The outcome measures are assessed up to 2 years.
|
合作者和调查者
调查人员
- 首席研究员:Zhongshan Hospital, PhD、Fudan University, Shanghai,China
研究记录日期
研究主要日期
学习开始 (预期的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.